Potential Implications of Rescheduling with Igor Grant, MD

In episode 2 (Recorded in December 2024), Drs. Igor Grant and Jamie Corroon discuss the potential implications of rescheduling cannabis from a Schedule I to a Schedule III controlled substance. They explore the current scheduling system, the medicinal value of cannabis, the challenges researchers face under Schedule I, and how rescheduling could impact research and funding. They also emphasize the need for harmonization between state and federal laws to facilitate cannabis research.

Igor Grant, M.D., is Distinguished Professor of the Department of Psychiatry at the University of California, San Diego School of Medicine. Dr. Grant served as Chair of the Department of Psychiatry from 2014-2019. He is Director of the HIV Neurobehavioral Research Program (HNRP), which includes the California NeuroAIDS Tissue Network (CNTN), the Translational Methamphetamine AIDS Research Center (TMARC), the HIV Neurobehavioral Research Center (HNRC), the CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) and the University of California Center for Medicinal Cannabis Research (CMCR). Dr. Grant is the founding Editor of the Journal of the International Neuropsychological Society and founding co-editor of the journal AIDS and Behavior.